We listen. We refine.
We go beyond.

Medicontur

Beyond
better

escrs.medicontur.com

Evidence

Continuous progress
grounded in evidence.

Experience what's beyond at boothsC.215&C.300

Explore What’s Beyond at ESCRS

Trifocal IOL

Liberty®

Liberty is a trifocal IOL engineered with advanced optical design and physiological alignment to deliver true spectacle independence and high-quality vision across all distances.

96 %
spectacle independence

The vast majority of the patients implanted with the Liberty trifocal IOL achieved complete spectacle independence at all distances.1,4

93%
not disturbed by photic phenomena

The centralized apodized diffractive rings reduce symptoms of postoperative glare and halos, which would not be found bothersome by the patients.2,3

7
ring EPS design

The Liberty trifocal IOL features seven progressively apodized diffractive rings within the central 3.0 mm of its 6.0 mm optic, with a refractive periphery.

10 years
stable performance

Clinical data from 10-year follow-up provide evidence that the Liberty IOL delivers excellent vision at all distances while maintaining long-term refractive stability.10

Proven visual freedom,
designed to last.

Technology overview
Liberty® trifocal IOL

EDOF IOL

ELON

ELON is a non-diffractive EDoF IOL using proprietary Wavefront Linking technology to create a true elongated focus, delivering continuous functional vision for active patients.

100%
of patients would choose again

All patients would choose ELON again, reflecting strong satisfaction in their postoperative visual experience.5

91%
within ±0.50 D of target refraction

ELON’s refractive optic with Wavefront Linking design supports precise refractive targeting and predictable postoperative outcomes.5

76%
complete spectacle independence

Three-quarters of patients implanted with ELON enjoy complete freedom from glasses in their daily activities.6

1.9º
mean value of rotation

The Bi-Flex double-loop haptic design minimizes the risk of rotation or displacement after implantation.6

The path to greater
visual freedom.

Technology overview
ELON EDoF IOL

Sulcus-based IOL

1stQ AddOn®

The 1stQ AddOn® is a new generation sulcus based IOL technology that provides you with new options for your patients, irrespective of their lens status and eye health.

Upgrade
monofocal vision

In monofocal pseudophakic eyes, the trifocal AddOn IOL achieves visual performance equal to that of a primary trifocal IOL implanted in the capsular bag.7

Adapt
vision for patient needs

The AddOn IOL offers tailor-made vision correction for individual patient needs, even after previous refractive surgery.8

Refine
residual refraction

The AddOn IOL offers an effective solution for refining residual refractive errors in pseudophakic eyes and serves as an alternative to laser vision correction.9

Reverse
trifocality anytime

The duet procedure allows patients to trial multifocal vision, with safe and simple removal of the sulcus IOL if intolerance persists.7

One solution.
Multiple possibilities.

Technology overview
1stQ AddOn® sulcus IOL
Network

Find your local distributor

Medicontur products are available through a trusted partner network across more than 75+ countries. Browse our distributor directory to find the contact closest to you.

Search distributors
Contact

Let's Go Beyond Together

Connect with us to explore solutions tailored to your needs.

contact us

References

1. Cervantes-Coste G, Tapia A, Corredor-Ortega C, Osorio M, Valdez R, Massaro M, Velasco-Barona C, Gonzalez-Salinas R. The influence of angle alpha, angle kappa, and optical aberrations on visual outcomes after the implantation of a high-addition trifocal IOL. Journal of Clinical Medicine. 2022 Feb 8;11(3):896.

2. Fernández J, Srinivasan S, Burguera N, Martínez J, Rodríguez-Vallejo M. One-year follow-up of a multifocal intraocular lens with optimized elevated phase shift. J Cataract Refract Surg. 2023 Oct 1;49(10):1018-1024. doi: 10.1097/j.jcrs.0000000000001266. PMID: 37464551.

3. Győry JF, Srinivasan S, Madar E, Balla L. Long-term performance of a diffractive-refractive trifocal IOL with centralized diffractive rings: 5-year prospective clinical trial. J Cataract Refract Surg. 2021;47(10):1258-1264. doi:10.1097/j.jcrs.0000000000000670.

4. Cano-Ortiz A, Sánchez-Ventosa Á, Villalba-González M, González-Cruces T, Prados-Carmona JJ, Díaz-Mesa V, et al. Clinical and patient reported outcomes of an optimized trifocal intraocular lens. J Clin Med. 2024;13(14):4133. doi:10.3390/jcm13144133.

5. Fernández, J., Burguera, N., Rodríguez-Calvo-de-Mora, M., Rocha-de-Lossada, C. & Rodríguez-Vallejo, M. One-year outcomes after implantation of an EDOF intraocular lens in patients with cataract. J. Cataract Refract. Surg. 51, 955–962 (2025).

6. Jančárová S, Němcová M, Rozsíval P, Nováček LV. Clinical results following the implantation of a new toric intraocular lens with extended depth of focus. Cesk Slov Oftalmol. 2026;82(1):35–40. doi:10.31348/2025/25.

7. Harrisberg BP, Chua AW, Chua MJ, Taher A. Comparison of primary duet lens procedures: in-the-bag monofocal with sulcus multifocal, and standard single multifocal lens for cataract surgery. Clinical Ophthalmology. 2023 Dec 31:273-82.

8. Gundersen KG, Gjerdrum B, Potvin R. Efficacy of a secondary trifocal sulcus IOL in providing near and intermediate vision in patients with prior myopic laser vision correction and cataract surgery. Clinical Ophthalmology. 2022 Jul 8:2219-26.

9. McLintock CA, McKelvie J, Niyazmand H, Apel AJ. Outcomes of a toric monofocal piggyback intraocular lens for residual astigmatic refractive error in pseudophakic eyes. Current Eye Research. 2022 Mar 4;47(3):443-9.

10. Data on file.